Clinical Trial Update: microRNAs in Systemic Scleroderma

View source ↗

Summary

The document notes that a clinical trial examining microRNAs in systemic sclerosis has completed. No efficacy or safety results are provided in the summary.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Sclerosis

Snippet

Sponsor: Centre Hospitalier Universitaire de Nice | Conditions: Scleroderma, Systemic | Status: COMPLETED